Evidence map›Paper›PMID 35183227›Full record

ArticleBMC research notes2022

Assessment of deep learning algorithms to predict histopathological diagnosis of breast cancer: first Moroccan prospective study on a private dataset.

H El Agouri, M Azizi, H El Attar, M El Khannoussi, A Ibrahimi, R Kabbaj, H Kadiri, S BekarSabein, S EchCharif, C Mounjid and 1 more

Abstract read
In one paragraph

Article in BMC research notes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Machine Learning Research Trends in Africa: A 30 Years Overview with Bibliometric Analysis Review.Archives of computational methods in engineering : state of the art reviews · 2023
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

H El AgouriPathology Department, Oncology National Institute, Faculty of Medicine and Pharmacy, Mohammed V University, 10100, Rabat, Morocco. hajar.elagouri@gmail.com.ORCID http://orcid.org/0000-0001-5692-3160
M AziziDatapathology, 20000, Casablanca, Morocco.
H El AttarAnatomic Pathology Laboratory Ennassr, 24000, El Jadida, Morocco.
M El KhannoussiDatapathology, 20000, Casablanca, Morocco.
A IbrahimiMedical Biotechnology Laboratory (MedBiotech), Bioinova Research Center, Rabat Medical & Pharmacy School, Mohammed Vth University in Rabat, 10100, Rabat, Morocco.
R KabbajPathology Department, Oncology National Institute, Faculty of Medicine and Pharmacy, Mohammed V University, 10100, Rabat, Morocco.
H KadiriPathology Department, Oncology National Institute, Faculty of Medicine and Pharmacy, Mohammed V University, 10100, Rabat, Morocco.
S BekarSabeinPathology Department, Oncology National Institute, Faculty of Medicine and Pharmacy, Mohammed V University, 10100, Rabat, Morocco.
S EchCharifPathology Department, Oncology National Institute, Faculty of Medicine and Pharmacy, Mohammed V University, 10100, Rabat, Morocco.
C MounjidPathology Department, Oncology National Institute, Faculty of Sciences, Mohammed V University, 10100, Rabat, Morocco.
B El KhannoussiPathology Department, Oncology National Institute, Faculty of Medicine and Pharmacy, Mohammed V University, 10100, Rabat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBreast cancer is a critical public health issue and a leading cause of cancer-related deaths among women worldwide. Its early diagnosis and detection can effectively help in increasing the chances of survival rate. For this reason, the diagnosis and classification of breast cancer using Deep learning algorithms have attracted a lot of attention. Therefore, our study aimed to design a computational approach based on deep convolutional neural networks for an efficient classification of breast cancer histopathological images by using our own created dataset. We collected overall 328 digital slides, from 116 of surgical breast specimens diagnosed with invasive breast carcinoma of non-specific type, and referred to the histopathology department of the National Institute of Oncology in Rabat, Morocco. We used two models of deep neural network architectures in order to accurately classify the images into one of three categories: normal tissue-benign lesions, in situ carcinoma or invasive carcinoma.

resultsBoth Resnet50 and Xception models achieved comparable results, with a small advantage to Xception extracted features. We reported high degrees of overall correct classification accuracy (88%), and sensitivity (95%) for detection of carcinoma cases, which is important for diagnostic pathology workflow in order to assist pathologists for diagnosing breast cancer with precision. The results of the present study showed that the designed classification model has a good generalization performance in predicting diagnosis of breast cancer, in spite of the limited size of the data. To our knowledge, this approach can be highly compared with other common methods in the automated analysis of breast cancer images reported in literature.

Indexed as

Breast NeoplasmsDeep LearningAlgorithmsFemaleHumansNeural Networks, ComputerProspective StudiesArtificial intelligenceBreast cancerConvolutional Neural NetworksDeep learningDigital pathologyMachine learning

Identifiers

PMID35183227
PMCPMC8857730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.